protein structure communications
Atomic resolution (0.97 Å) structure of the triple mutant (K53,56,121M) of bovine pancreatic phospholipase A2
aBioinformatics Centre, Indian Institute of Science, Bangalore 560 012, India, bSupercomputer Education and Research Centre, Indian Institute of Science, Bangalore 560 012, India, cDepartment of Crystallography and Biophysics, University of Madras, Guindy Campus, Chennai 600 025, India, dDepartment of Chemistry and Biochemistry and The Ohio State Biotechnology Program, The Ohio State University, Columbus, OH 43210, USA, eAcademia Sinica, Taiwan, fSAIC-Frederick Inc., Basic Research Program, Brookhaven National Laboratory, Building 725A-X9, Upton, NY 11973, USA, and gSynchrotron Radiation Research Section, Macromolecular Crystallography Laboratory, NCI and Brookhaven National Laboratory, Building 725A-X9, Upton, NY 11973, USA
*Correspondence e-mail: sekar@physics.iisc.ernet.in
The enzyme phospholipase A2 catalyzes the hydrolysis of the sn-2 acyl chain of forming and lysophospholipids. The of a triple mutant (K53,56,121M) of bovine pancreatic phospholipase A2 in which the lysine residues at positions 53, 56 and 121 are replaced recombinantly by methionines has been determined at atomic resolution (0.97 Å). The crystal is monoclinic (space group P2), with unit-cell parameters a = 36.934, b = 23.863, c = 65.931 Å, β = 101.47°. The structure was solved by and has been refined to a final R factor of 10.6% (Rfree = 13.4%) using 63 926 unique reflections. The final protein model consists of 123 amino-acid residues, two calcium ions, one chloride ion, 243 water molecules and six 2-methyl-2,4-pentanediol molecules. The surface-loop residues 60–70 are ordered and have clear electron density.
Keywords: phospholipase A2.
3D view: 1vl9
PDB reference: K53,56,121M bovine pancreatic PLA2, 1vl9, r1vl9sf
1. Introduction
Pancreatic phospholipase A2 (PLA2), a subfamily of the growing PLA2 superfamily (Dennis, 1994, 1997), hydrolyzes the sn-2 ester bond of 3-sn-phospholipids. These calcium-dependent and highly homologous enzymes are typically small (13–15 kDa), but possess several interesting structural features. The PLA2 enzyme is one of the better characterized lipolytic enzymes, particularly with respect to enzymatic mechanism. The first detailed structural analysis of this enzyme was carried out by Dijkstra and coworkers (Dijkstra et al., 1978, 1981), which together with further biochemical data led to a proposed catalytic mechanism (Scott et al., 1990; Thunnissen et al., 1990; Verheij et al., 1980). In most of the structures of recombinant bovine pancreatic PLA2 and its mutants, the residues in a surface loop in the region 60–70 have been found to be disordered (Huang et al., 1996; Sekar, Yu et al., 1997; Sekar, Kumar et al., 1998; Sekar, Sekharudu et al., 1998; Sekar et al., 1999, 2003; Yu et al., 2000). The loop has also been found in a well ordered conformation in several structures (Rajakannan et al., 2002; Sekar, Eswaramoorthy et al., 1997; Sekar et al., 2003; Sekar & Sundaralingam, 1999; Steiner et al., 2001). Since mutations of lysine residues to methionine at positions 53, 56, 120 and 121 are found to enhance the binding of the enzyme in zwitterionic interfaces (Yu et al., 2000), three different combinations of these mutations, K53,56M (designated to indicate that lysines at positions 53 and 56 are replaced by methionine residues; Yu et al., 2000), K56,120,121M (similarly mutated at residues 56, 120 and 121; Rajakannan et al., 2002) and K53,56,120M (Sekar et al., 2003, 2004), have been crystallized and studied. To further unravel the structural features associated with these mutations, we have undertaken the of the triple mutant K53,56,121M of bovine pancreatic PLA2.
2. Materials and methods
2.1. Construction of K53/56/121M PLA2 mutant
The mutant PLA2 was generated by site-directed mutagenesis. The following complementary sets of were used: 5′-CATGATAATTGCTATATGCAAGCTAAAAAACTT-3′ (K53M), 5′-TGCTATAAACAAGCTATGAAACTTGATAGCTGC-3′ (K56M) and 5′-CAAGAATCTTGATAAAATGAACTGTTAAGCTTCT-3′ (K121M). The Quickchange method by Stratagene was employed using pET25b(m)-proPLA2 as template. The single mutant K53M was first generated and the double (K53,56M) and triple (K53,56,121M) mutants were then generated using the single mutant and double mutant, respectively, as template DNA. The recombinant bovine pancreatic PLA2 protein was expressed in Escherichia coli BL21(DE3) pLysS strain as inclusion bodies and was refolded and purified as described elsewhere (Liu et al., 1995; Zhu et al., 1995).
2.2. Crystallization, data collection and processing
The protein samples were lyophilized upon dialysis against distilled H2O following a QSFF ion-exchange chromatographic separation. The QSFF buffer consisted of 10 mM Tris adjusted to pH 8.4–8.5 using NaOH and the elution gradient used was 50–100 mM NaCl. The elution fraction collected was between 50 and 100 ml in volume and was then dialyzed against 8 l of distilled H2O. The usual range of final protein product was between 15 and 30 mg. Therefore, the estimated salt components carried over were between 10 and 125 mM NaCl and 5 and 15 mM Tris. The exact salt content carried over from the purification process was difficult to determine because the purification process could vary slightly from batch to batch owing to the elaborate procedures involved.
Lyophilized protein (powder form) samples of the present triple mutant were dissolved in 50 mM Tris buffer pH 7.2 containing 5 mM CaCl2 to a final protein concentration of 17–20 mg ml−1. The crystallization droplet contained 5 µl protein solution and 3 µl 60%(v/v) 2-methyl-2,4-pentanediol (MPD) and the reservoir contained 70%(v/v) MPD. The hanging-drop vapour-diffusion method was employed and crystals appeared in about two weeks. High-quality X-ray diffraction data were collected from a single crystal measuring 0.40 × 0.30 × 0.30 mm at liquid-nitrogen temperature (100 K). The intensity data were collected on beamline X9B (National Synchrotron Light Source, Brookhaven National Laboratory, Upton, NY, USA) using an ADSC Quantum 4 CCD detector. Data were processed and scaled using the HKL2000 suite of programs (Otwinowski & Minor, 1997) and the associated statistics are given in Table 1.
|
2.3. Structure solution and refinement
The 1.9 Å resolution model of bovine pancreatic PLA2 (Rajakannan et al., 2002; PDB code 1gh4 ) was used for (Navaza, 1994). The resultant model was subjected to rigid-body which led to an R factor of 23.5% [Rfree = 24.1%; Brünger, 1992). At this stage, 20 cycles of with REFMAC (Murshudov et al., 1999) were performed and the resolution was extended stepwise to 0.97 Å. Subsequently, ten cycles of using REFMAC combined with ARP/wARP (Perrakis et al., 1999) were performed and a total of 164 water molecules were located and added to the model, giving an R factor (F > 4σ) of 19.5% (Rfree = 21.3%). Inspection of the difference electron-density maps indicated minor adjustments for the side chains of Trp3, Gln4, Leu31 and Lys120 and these were performed with the molecular-modelling program FRODO (Jones, 1985). Moreover, clear signs of anisotropy present in the electron density for several residues suggested possible alternate side-chain conformations. 20 cycles of anisotropic were carried out for all the residues with inclusion of H atoms at calculated positions and decreased the R factor to 14.3% (Rfree = 17.6%). A manual rebuilding step was performed followed by a few cycles of conjugate-gradient least-squares using SHELXL (Sheldrick & Schneider, 1997). The side chains of 14 amino-acid residues (Leu2, Trp3, Gln4, Lys10, Leu31, Met53, Met56, Lys108, Lys113, Lys116, Leu118, Lys120, Met121 and Asn122) were modelled with more than one side-chain position. Modelling of alternate conformations was carried out in the anisotropic model. A total of six MPD molecules, two calcium ions and one chloride ion were identified and included in the The positions of the second calcium ion and the chloride ion are consistent with those found in the prior atomic resolution structure of the enzyme (Steiner et al., 2001) and also with our recent structure of the K53,56,120M mutant (Sekar et al., 2004). of the extensively rebuilt model, which included 11 further residues (Arg43, Asn50, Gln54, Lys57, Leu58, Lys62, Ser74, Ser76, Glu81, Ser86 and Glu114) with alternate conformations, led to an R factor of 12.1% (Rfree = 14.9%). Additional water O atoms were located and included in the (water molecules with occupancies lower than 0.2 are removed from the refinement), which reduced the final R factor to 10.6% (Rfree = 13.4%) and those that had higher than 0.95 were treated as having unit occupancy. These water molecules were also refined anisotropically. The R factor at this stage was 11.7% for all reflections. are given in Table 1.
3. Results and discussion
3.1. Quality of the model
The final refined model consists of 123 amino-acid residues, two calcium ions, one chloride ion, six MPD molecules and 243 crystallographic water molecules (137 water molecules have unit occupancy). The conventional R factor (F > 4σ) for the refined model is 10.6% (Rfree = 13.4%). In general, the electron density is clear for all the residues. A Ramachandran plot calculated using PROCHECK (Laskowski et al., 1993) shows 92.7% of the residues in most favoured regions and the remaining residues in additionally allowed regions. The overall fold is similar to that of the previously reported structures (Sekar, Sekharudu et al., 1998; Sekar & Sundaralingam, 1999; Steiner et al., 2001). In the present anisotropic model, the side chains of 25 residues have been modelled in two discrete alternate conformations and the atoms are clearly visible in the electron-density map contoured at the 1.2σ level.
3.2. Surface loop
The refined model shows well defined electron density for all the residues in the surface loop in the region of positions 60–70 (Fig. 1). Superposition of the backbone atoms of the surface-loop residues with those of the monoclinic triple mutant (K56,120,121M; Rajakannan et al., 2002) shows a root-mean-square (r.m.s.) deviation of 0.31 Å (Fig. 2a). However, the deviation of the corresponding residues is 2.53 Å (PDB code 1une ) and 2.55 Å (PDB code 1g4i ), respectively (Fig. 2b), when superimposed with corresponding residues in the orthorhombic forms (Sekar & Sundaralingam, 1999; Steiner et al., 2001).
3.3. Second calcium ion
As observed earlier in the triple mutant K56,120,121M (Rajakannan et al., 2002), the present atomic resolution model also features a second calcium ion, which is coordinated by six ligand atoms (three from protein and three water molecules). The protein-ligand atoms are the side-chain atom Oδ1 of Asn71, the backbone carbonyl O atom of Asn72 and the carboxylate atom O∊2 of Glu92 and the ligand distances are 2.29, 2.37 and 2.35 Å, respectively. The three water-ligand distances are 2.31, 2.44 and 2.60 Å. One of the water molecules is modelled as having alternative positions, one of which is at a distance of 2.31 Å from the second calcium ion and the other at a distance of 2.37 Å. The occupancies are 0.7 and 0.3, respectively. The corresponding ligand distance in the earlier reported triple mutant (Rajakannan et al., 2002) was 2.44 Å. All the three water O atoms liganded to the second calcium ion are involved in indirect hydrogen bonding (Figs. 2a and 2b) with the residues Ser60, Val65 and Asp66 in the surface loop through other water O atoms. To further substantiate this interaction, we compared the conformations of the surface loops in the inhibitor-bound PLA2 structures (Sekar, Eswaramoorthy et al., 1997; Sekar, Kumar et al., 1998; Sekar et al., 2003) with those in the structures where we have located the second calcium ion (the present model and the triple mutant K56,120,121M; Rajakannan et al., 2002) and this comparison is shown in Fig. 3. It is clear that the conformation of the surface loop observed in PLA2 structures where a second calcium ion is bound is different to that observed in structures of inhibitor-bound PLA2 complexes. We propose that the hydrogen-bonding network induced by the second calcium ion is responsible for the alternate surface-loop conformation. While we suspect that crystal packing and the second calcium ion have roles to play, in the final analysis we are uncertain of what causes the ordering of the 60–70 loop. It would be interesting to see the conformation of the surface loop in a structure containing both inhibitor as well as the second calcium ion.
3.4. Chloride ion
A huge peak (>6σ) is observed in the present model and is assigned as a chloride ion. A literature survey showed that a chloride ion has been observed in the wild-type enzyme (Steiner et al., 2001) in the same position that a strong peak is seen in the present study. The chloride ion makes close contacts with the side-chain N atom of Lys12 (3.15 Å), the main-chain N atom of Ile82 (3.15 Å) and Arg100 Nδ2 (3.44 Å).
3.5. Water molecules
A total of 243 water O atoms are modelled in the present model. Of these, 137 have unit occupancy and the remainder are partially occupied. The first hydration shell contains 201 water O atoms, while the second hydration shell contains 36. The remaining six water O atoms have no interactions with protein atoms, water O atoms in the hydration shells or ions.
3.6. MPD molecules
Six MPD molecules are observed in the present model, while five were found in the earlier atomic resolution study (Steiner et al., 2001). One MPD molecule, located at the surface of the protein near the helix containing residues Glu17–Phe22, is common to both structures. The remaining five MPD molecules in the present structure are observed around the active-site calcium ion. Instead of a cluster of three MPD molecules (with partial occupancies) at the entrance of the hydrophobic channel leading to the active site (Steiner et al., 2001), only one MPD molecule with full occupancy is observed in the present structure.
4. Conclusions
The present structure provides a second example of a second calcium ion bound near the N-terminus in these mutant PLA2s. Additionally, efforts are under way to co-crystallize various potential inhibitors to the triple mutants (K53,56,121M and K56,120,121M) to determine whether the inhibitor binds to the second calcium ion and also to study the dynamics of the surface loop.
Supporting information
3D view: 1vl9
PDB reference: K53,56,121M bovine pancreatic PLA2, 1vl9, r1vl9sf
Acknowledgements
The authors gratefully acknowledge the use of interactive graphics-based molecular modelling at the Supercomputer Education and Research Centre and the Distributed Information Centre. DV thanks SAIC-Frederick Inc., Basic Research Program, BNL for the visiting scientist fellowship and also thanks the UGC for financial support. VR thanks the Council of Scientific and Industrial Research for a Senior Research Fellowship. The work in Dr Tsai's laboratory was supported by NIH grants GM 41788 and GM 57568.
References
Brünger, A. T. (1992). Nature (London), 355, 472–474. PubMed Web of Science Google Scholar
Dennis, E. A. (1994). J. Biol. Chem. 269, 13057–13060. CAS PubMed Web of Science Google Scholar
Dennis, E. A. (1997). Trends Biochem. Sci. 22, 1–2. CrossRef CAS PubMed Web of Science Google Scholar
Dijkstra, B. W., Drenth, J., Kalk, K. H. & Vandermaelen, P. J. (1978). J. Mol. Biol. 124, 53–60. CrossRef CAS PubMed Web of Science Google Scholar
Dijkstra, B. W., Kalk, K. H., Hol, W. G. J. & Drenth, J. (1981). J. Mol. Biol. 147, 97–123. CrossRef CAS PubMed Web of Science Google Scholar
Huang, B., Yu, B. Z., Rogers, J., Byeon, I. J., Sekar, K., Chen, X., Sundaralingam, M., Tsai, M.-D. & Jain, M. K. (1996). Biochemistry, 35, 12164–12174. CrossRef CAS PubMed Web of Science Google Scholar
Jones, T. A. (1985). Methods Enzymol. 115, 157–171. CrossRef CAS PubMed Google Scholar
Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. (1993). J. Appl. Cryst. 26, 283–291. CrossRef CAS Web of Science IUCr Journals Google Scholar
Liu, X., Zhu, H., Huang, B., Rogers, J., Yu, B.-Z., Kumar, A., Jain, M. K., Sundaralingam, M. & Tsai, M.-D. (1995). Biochemistry, 34, 7322–7334. CrossRef CAS PubMed Web of Science Google Scholar
Murshudov, G. N., Vagin, A. A., Lebedev, A., Wilson, K. S. & Dodson, E. J. (1999). Acta Cryst. D55, 247–255. Web of Science CrossRef CAS IUCr Journals Google Scholar
Navaza, J. (1994). Acta Cryst. A50, 157–163. CrossRef CAS Web of Science IUCr Journals Google Scholar
Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326. CrossRef CAS Web of Science Google Scholar
Perrakis, A., Morris, R. J. & Lamzin, V. S. (1999). Nature Struct. Biol. 6, 458–463. Web of Science CrossRef PubMed CAS Google Scholar
Rajakannan, V., Yogavel, M., Poi, M.-J., Jeyaprakash, A. A., Jeyakanthan, J., Velmurugan, D., Tsai, M.-D. & Sekar, K. (2002). J. Mol. Biol. 324, 755–762. Web of Science CrossRef PubMed CAS Google Scholar
Scott, D. L., White, S. P., Otwinowski, Z., Yuan, W., Gelb, M. H. & Sigler, P. B. (1990). Science, 250, 1541–1546. CrossRef CAS PubMed Web of Science Google Scholar
Sekar, K., Biswas, R., Li, Y., Tsai, M.-D. & Sundaralingam, M. (1999). Acta Cryst. D55, 443–447. Web of Science CrossRef CAS IUCr Journals Google Scholar
Sekar, K., Eswaramoorthy, S., Jain, M. K. & Sundaralingam, M. (1997). Biochemistry, 36, 14186–14191. CrossRef CAS PubMed Web of Science Google Scholar
Sekar, K., Kumar, A., Liu, X., Tsai, M.-D., Gelb, M. H. & Sundaralingam, M. (1998). Acta Cryst. D54, 334–341. Web of Science CrossRef CAS IUCr Journals Google Scholar
Sekar, K., Rajakannan, V., Velmurugan, D., Yamane, T., Thirumurugan, R., Dauter, M. & Dauter, Z. (2004). Acta Cryst. D60, 1586–1590. Web of Science CrossRef CAS IUCr Journals Google Scholar
Sekar, K., Sekharudu, C., Tsai, M.-D. & Sundaralingam, M. (1998). Acta Cryst. D54, 342–346. Web of Science CrossRef CAS IUCr Journals Google Scholar
Sekar, K. & Sundaralingam, M. (1999). Acta Cryst. D55, 46–50. Web of Science CrossRef CAS IUCr Journals Google Scholar
Sekar, K., Vaijayanthi Mala, S., Yogavel, M., Velmurugan, D., Poi, M.-J., Vishwanath, B. S., Gowda, T. V., Jeyaprakash, A. A. & Tsai, M.-D. (2003). J. Mol. Biol. 333, 367–376. Web of Science CrossRef PubMed CAS Google Scholar
Sekar, K., Yu, B.-Z., Roger, J., Lutton, J., Liu, X., Chen, X., Tsai, M.-D., Jain, M. K. & Sundaralingam, M. (1997). Biochemistry, 36, 3104–3114. CrossRef CAS PubMed Web of Science Google Scholar
Sheldrick, G. M. & Schneider, T. R. (1997). Methods Enzymol. 277, 319–343. CrossRef PubMed CAS Web of Science Google Scholar
Steiner, R. A., Rozeboom, H. J., de Vries, A. A., Kalk, K. H., Murshudov, G. N., Wilson, K. S. & Dijkstra, B. W. (2001). Acta Cryst. D57, 516–526. Web of Science CrossRef CAS IUCr Journals Google Scholar
Thunnissen, M. M. G. M., Eiso, A. B., Kalk, K. H., Drenth, J., Dijkstra, B. W., Kuipers, O. P., Dijkman, R., de Haas, G. H. & Verheij, H. M. (1990). Nature (London), 347, 689–691. CrossRef CAS PubMed Web of Science Google Scholar
Verheij, H. M., Volwerk, J. J., Jansen, E. H., Puyk, W. C., Dijkstra, B. W., Drenth, J. & de Haas, G. H. (1980). Biochemistry, 19, 743–750. CrossRef CAS PubMed Web of Science Google Scholar
Yu, B.-Z., Poi, M.-J., Ramagopal, U. A., Jain, R., Ramakumar, S., Berg, O. G., Tsai, M.-D., Sekar, K. & Jain, M. K. (2000). Biochemistry, 39, 12312–12323. Web of Science CrossRef PubMed CAS Google Scholar
Zhu, H., Dupureur, C. M., Zhang, X. & Tsai, M.-D. (1995). Biochemistry, 34, 15307–15314. CrossRef CAS PubMed Web of Science Google Scholar
© International Union of Crystallography. Prior permission is not required to reproduce short quotations, tables and figures from this article, provided the original authors and source are cited. For more information, click here.